Loading...

Siegfried Holding AG

SFZN.SWSIX
HealthcareDrug Manufacturers - Specialty & Generic
$97.60
$2.60(2.74%)

Siegfried Holding AG (SFZN.SW) Stock Overview

Explore Siegfried Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
1.82%
1.82%
Profit Growth
$30.06
41.93%
EPS Growth
$30.06
39.57%
Operating Margin
13.98%
15.80%
ROE
13.96%
41.93%
Dividend Yield
0.00%
4.79%
Analyst Recommendations data is not available for SFZN.SWAnalyst Recommendations details for SFZN.SW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Siegfried Holding AG engages in the life sciences business worldwide. The company develops and produces active pharmaceutical ingredients (APIs) and intermediates, as well as finished dosage forms, including solid oral dosage forms, and sterile and aseptic filling injectables, ophthalmics, and inhalative products. It offers contract development and manufacturing services, including pharmaceutical and analytical development, process and analytical transfer, commercial manufacturing and packaging, and scale up and clinical trial material production. In addition, the company provides APIs and controlled substances focusing on anesthetics, pain treatment applications, and central nervous and respiratory diseases. Further, it licenses oral solid and sterile products; assembles registration dossiers; and offers a common technical document for various products. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.

CEO

Mr. Marcel Imwinkelried

Employees

3,886

Headquarters

Untere Bruehlstrasse 4, Zofingen

Founded

1995

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.